Sentinel Trust’s AbbVie ABBV Stock Holding History

Sentinel Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71M	Hold	14,743	–	–	0.33%	38
2026 Q1	$3.21M	Hold	14,743	–	–	0.32%	34
2025 Q4	$3.37M	Hold	14,743	–	–	0.33%	35
2025 Q3	$3.41M	Sell	14,743 -800	-5%	-$163K	0.35%	35
2025 Q2	$2.88M	Hold	15,543	–	–	0.31%	40
2025 Q1	$3.26M	Sell	15,543 -601	-4%	-$117K	0.38%	35
2024 Q4	$2.87M	Buy	16,144 +601	+4%	+$110K	0.33%	41
2024 Q3	$3.07M	Hold	15,543	–	–	0.35%	43
2024 Q2	$2.67M	Hold	15,543	–	–	0.33%	47
2024 Q1	$2.83M	Hold	15,543	–	–	0.37%	42
2023 Q4	$2.41M	Hold	15,543	–	–	0.32%	45
2023 Q3	$2.32M	Buy	15,543 +418	+3%	+$61.4K	0.33%	46
2023 Q2	$2.04M	Hold	15,125	–	–	0.28%	55
2023 Q1	$2.41M	Buy	+15,125	New	+$2.31M	0.34%	43
2022 Q1	–	Sell	-2,070	Closed	-$280K	–	138
2021 Q4	$280K	Buy	+2,070	New	+$245K	0.03%	123
2018 Q4	–	Sell	-12,103	Closed	-$1.15M	–	87
2018 Q3	$1.15M	Sell	12,103 -3,497	-22%	-$332K	0.25%	73
2018 Q2	$1.45M	Sell	15,600 -21,600	-58%	-$2.11M	0.32%	66
2018 Q1	$3.52M	Sell	37,200 -4,810	-11%	-$528K	0.74%	45
2017 Q4	$4.06M	Sell	42,010 -1,870	-4%	-$176K	0.84%	38
2017 Q3	$3.9M	Buy	+43,880	New	+$3.34M	0.66%	46
2014 Q2	–	Sell	-6,026	Closed	-$310K	–	145
2014 Q1	$310K	Sell	6,026 -1,510	-20%	-$76.3K	0.09%	113
2013 Q4	$398K	Sell	7,536 -50	-0.7%	-$2.46K	0.11%	120
2013 Q3	$339K	Sell	7,586 -625	-8%	-$27.7K	0.1%	131
2013 Q2	$339K	Buy	+8,211	New	+$359K	0.1%	132

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sentinel Trust's ABBV Position: Q2 2026 in Review

Sentinel Trust held its AbbVie (ABBV) position steady in Q2 2026 at 14,743 shares worth $3.71M. The position accounts for 0.33% of the portfolio, ranked #38.

Sentinel Trust first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.06M in Q4 2017. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Sentinel Trust held 14,743 shares of AbbVie worth $3.71M as of Q2 2026.
Sentinel Trust left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.33% of Sentinel Trust's portfolio in Q2 2026, its #38 holding.
Sentinel Trust first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
Sentinel Trust's AbbVie position peaked at $4.06M in Q4 2017.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.